Pasar al contenido principal

HETEROGENEIDAD GENOMICA DE LAS CELULAS TUMORALES CIRCULANTES

PID2019-106247GB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSIDAD DE VIGO

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Single-cell mtDNA heteroplasmy in colorectal cancer

  • Almeida, João
  • Pérez Figueroa, Andrés
  • Fernandes Alves, Joao Miguel
  • Valecha , Monica Vishnu
  • Prado López, Sonia
  • Alvariño Sanjurjo, Pilar
  • Cameselle Teijeiro, José Manuel
  • Chantada De La Fuente, Débora
  • Fonseca, Miguel M.
  • Posada González, David
Financiado para publicación en acceso aberto: Universidade de Vigo/CISUG, Human mitochondria can be genetically distinct within the same individual, a phenomenon known as heteroplasmy. In cancer, this phenomenon seems exacerbated, and most mitochondrial mutations seem to be heteroplasmic. How this genetic variation is arranged within and among normal and tumor cells is not well understood. To address this question, here we sequenced single-cell mitochondrial genomes from multiple normal and tumoral locations in four colorectal cancer patients. Our results suggest that single cells, both normal and tumoral, can carry various mitochondrial haplotypes. Remarkably, this intra-cell heteroplasmy can arise before tumor development and be maintained afterward in specific tumoral cell subpopulations. At least in the colorectal patients studied here, the somatic mutations in the single-cells do not seem to have a prominent role in tumorigenesis., Agencia Estatal de Investigación | Ref. PID2019-106247GB-I00
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Tesis doctoral (DoctoralThesis)

Genomic heterogeneity of circulating tumor cells, Heterogeneidad genómica de las células tumorales circulantes, Hetereoxeneidade xenómica das células tumorais circulantes

  • Varela Rouco, Nair
In this project we aim to leverage an evolutionary genomics approach to better understand how and when circulating tumor cells (CTCs) and CTC-clusters are able to initialize the metastatic process. As part of this, we want to understand which genetic changes increase the metastatic potential of CTCs, and whether CTC-clusters responsible for metastases are truly heterogeneous at the genomic level, endorsing the idea of clonal cooperation as a real phenomenon in cancer, reinforcing the role of CTC-clusters as key elements for the metastatic process., En este proyecto, nuestro objetivo es aprovechar el enfoque de la genómica evolutiva para comprender mejor cómo y cuándo las células tumorales circulantes (CTC) y los grupos de CTC pueden iniciar el proceso metastásico. Como parte de esto, queremos comprender qué cambios genéticos aumentan el potencial metastásico de las CTC y si los grupos de CTC responsables de las metástasis son realmente heterogéneos a nivel genómico, respaldando la idea de la cooperación clonal como un fenómeno real en el cáncer, reforzando el papel de los clústeres de CTC como elementos clave para el proceso metastásico., Neste proxecto, pretendemos aproveitar o enfoque da xenómica evolutiva para comprender mellor como e cando as células tumorais circulantes (CTC) e os grupos de CTC poden iniciar o proceso metastático. Como parte disto, queremos comprender cales son os cambios xenéticos que aumentan o potencial metastático dos CTC e se os grupos de CTC responsables das metástases son realmente heteroxéneos a nivel xenómico, apoiando a idea da cooperación clonal como un fenómeno real no cancro, reforzando o papel dos clústeres de CTC como elementos clave para o proceso metastático., Agencia Estatal de Investigación | Ref. PID2019-106247GB-I00, Agencia Estatal de Investigación | Ref. PRE2020-092269
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Clonality and timing of relapsing colorectal cancer metastasis revealed through whole-genome single-cell sequencing

  • Fernandes Alves, Joao Miguel
  • Prado Lopez, Sonia
  • Tomás López, Laura
  • Valecha , Monica Vishnu
  • Estevez Gomez, Nuria
  • Alvariño Sanjurjo, Pilar
  • Geisel, Dominik
  • Modest, Dominik Paul
  • Sauer, Igor M.
  • Pratschke, Johann
  • Raschzok, Nathanael
  • Sers, Christine
  • Mamlouk, Soulafa
  • Posada González, David
Financiado para publicación en acceso aberto: Universidade de Vigo/CISUG, Recurrence of tumor cells following local and systemic therapy is a significant hurdle in cancer. Most patients with metastatic colorectal cancer (mCRC) will relapse, despite resection of the metastatic lesions. A better understanding of the evolutionary history of recurrent lesions is required to identify the spatial and temporal patterns of metastatic progression and expose the genetic and evolutionary determinants of therapeutic resistance. With this goal in mind, here we leveraged a unique single-cell whole-genome sequencing dataset from recurrent hepatic lesions of an mCRC patient. Our phylogenetic analysis confirms that the treatment induced a severe demographic bottleneck in the liver metastasis but also that a previously diverged lineage survived this surgery, possibly after migration to a different site in the liver. This lineage evolved very slowly for two years under adjuvant drug therapy and diversified again in a very short period. We identified several non-silent mutations specific to this lineage and inferred a substantial contribution of chemotherapy to the overall, genome-wide mutational burden. All in all, our study suggests that mCRC subclones can migrate locally and evade resection, keep evolving despite rounds of chemotherapy, and re-expand explosively., Ministerio de Ciencia e Innovación | Ref. PID2019-106247GB-I00, AXA Research Fund, Asociación Española Contra el Cáncer, Xunta de Galicia | Ref. ED481A-2018/303
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Comparative analysis of capture methods for genomic profiling of circulating tumor cells in colorectal cancer

  • Fernandes Alves, Joao Miguel
  • Estevez Gomez, Nuria
  • Valecha , Monica Vishnu
  • Prado López, Sonia
  • Tomás López, Laura
  • Alvariño Sanjurjo, Pilar
  • Silva Piñeiro, Roberto
  • Muinelo Romay, Laura
  • Mondelo Macía, Patricia
  • Salgado, Mercedes
  • Iglesias Gómez, Agueda
  • Codesido Prada, Laura
  • Cubiella Fernández, Joaquín
  • Posada González, David
Financiado para publicación en acceso aberto: Universidade de Vigo/CISUG, The genomic profiling of circulating tumor cells (CTCs) in the bloodstream should provide clinically relevant information on therapeutic efficacy and help predict cancer survival. Here, we contrasted the genomic profiles of CTC pools recovered from metastatic colorectal cancer (mCRC) patients using different enrichment strategies (CellSearch, Parsortix, and FACS). Mutations inferred in the CTC pools differed depending on the enrichment strategy and, in all cases, represented a subset of the mutations detected in the matched primary tumor samples. However, the CTC pools from Parsortix, and in part, CellSearch, showed diversity estimates, mutational signatures, and drug-suitability scores remarkably close to those found in matching primary tumor samples. In addition, FACS CTC pools were enriched in apparent sequencing artifacts, leading to much higher genomic diversity estimates. Our results highlight the utility of CTCs to assess the genomic heterogeneity of individual tumors and help clinicians prioritize drugs in mCRC., Agencia Estatal de Investigación | Ref. PID2019-106247GB-I00, Xunta de Galicia | Ref. ED481A-2018/303, Instituto de Salud Carlos III | Ref. PI17/00837, Instituto de Salud Carlos III | Ref. PI21/01771, Axencia Galega de Innovación | Ref. N607B-2020/02, Axencia Galega de Innovación | Ref. IN853B 2018/03
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Genomic diversity and BCL9L mutational status in circulating tumor cells predict overall survival in metastatic colorectal cancer

  • Fernandes Alves, Joao Miguel
  • Estevez Gomez, Nuria
  • Piñeiro, Roberto
  • Muinelo Romay, Laura
  • Mondelo Macía, Patricia
  • Salgado, Mercedes
  • Iglesias Gómez, Agueda
  • Codesido Prada, Laura
  • Diez Martín, Astrid
  • Cubiella, Joaquin
  • Posada González, David
Background Metastatic colorectal cancer (mCRC) remains a major cause of cancer-related mortality, but few noninvasive biomarkers exist to track disease progression or inform treatment strategies. Circulating tumor cells (CTCs) offer a minimally invasive source of tumor material, yet the prognostic significance of their genomic diversity remains unclear. Methods We conducted whole-exome sequencing of CTC pools from 29 mCRC patients to characterize their mutational landscape and assess associations with overall survival. Results Our analysis revealed substantial variation in mutational burden among patients, with all CTC pools harboring non-silent mutations in key CRC driver genes. Higher genomic diversity in CTC pools was significantly associated with reduced overall survival. Additionally, non-silent mutations in BCL9L emerged as a strong predictor of patient survival. Conclusion Genomic diversity and BCL9L mutational status in CTC pools emerged as strong predictors of survival in mCRC, underscoring the potential of CTC genomic profiling as a minimally invasive and clinically relevant prognostic tool in mCRC., Agencia Estatal de Investigación | Ref. PID2019-106247GB-I00, Xunta de Galicia | Ref. ED431C 2022/26, Universidade de Vigo /CISUG
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

CellPhy: accurate and fast probabilistic inference of single-cell phylogenies from scDNA-seq data

  • Kozlov, Alexey
  • Fernandes Alves, Joao Miguel
  • Stamatakis, Alexandros
  • Posada González, David
We introduce CellPhy, a maximum likelihood framework for inferring phylogenetic trees from somatic single-cell single-nucleotide variants. CellPhy leverages a finite-site Markov genotype model with 16 diploid states and considers amplification error and allelic dropout. We implement CellPhy into RAxML-NG, a widely used phylogenetic inference package that provides statistical confidence measurements and scales well on large datasets with hundreds or thousands of cells. Comprehensive simulations suggest that CellPhy is more robust to single-cell genomics errors and outperforms state-of-the-art methods under realistic scenarios, both in accuracy and speed., European Research Council | Ref. ERC-617457- PHYLOCANCER, Agencia Estatal de Investigación | Ref. PID2019-106247GB-I00, Fundação para a Ciência e a Tecnologia | Ref. PTDC/BIA-EVL/32030/2017, Xunta de Galicia
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

SARS-CoV-2 genomic diversity and the implications for qRT-PCR diagnostics and transmission

  • Sapoval, Nicolae
  • Mahmoud, Medhat
  • Jochum, Michael D.
  • Liu, Yunxi
  • Elworth, R.A. Leo
  • Wang, Qi
  • Albin, Dreycey
  • Ogilvie, Huw A.
  • Lee, Michael D.
  • Villapol, Sonia
  • Hernández, Kyle M.
  • Maljkovic Berry, Irina
  • Foox, Jonathan
  • Beheshti, Afshin
  • Ternus, Krista
  • Aagaard, Kjersti M.
  • Posada González, David
  • Mason, Christopher E.
  • Sedlazeck, Fritz J.
  • Treangen, Todd J.
The COVID-19 pandemic has sparked an urgent need to uncover the underlying biology of this devastating disease. Though RNA viruses mutate more rapidly than DNA viruses, there are a relatively small number of single nucleotide polymorphisms (SNPs) that differentiate the main SARS-CoV-2 lineages that have spread throughout the world. In this study, we investigated 129 RNA-seq data sets and 6928 consensus genomes to contrast the intra-host and inter-host diversity of SARS-CoV-2. Our analyses yielded three major observations. First, the mutational profile of SARS-CoV-2 highlights intra-host single nucleotide variant (iSNV) and SNP similarity, albeit with differences in C > U changes. Second, iSNV and SNP patterns in SARS-CoV-2 are more similar to MERS-CoV than SARS-CoV-1. Third, a significant fraction of insertions and deletions contribute to the genetic diversity of SARS-CoV-2. Altogether, our findings provide insight into SARS-CoV-2 genomic diversity, inform the design of detection tests, and highlight the potential of iSNVs for tracking the transmission of SARS-CoV-2., National Institutes of Health | Ref. R01HD091731, National Institute of Allergy and Infectious Diseases | Ref. U19AI144297-01, National Aeronautics and Space Administration | Ref. NNX16AO69A, European Research Council | Ref. ERC-617457-PHYLOCANCER, Xunta de Galicia | Ref. CT850A-2, Ministerio de España de Economía y Competitividad | Ref. PID2019-106247GB-I00
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Tesis doctoral (DoctoralThesis)

Evolution and genomic heterogeneity in solid tumors, Evolución y heterogeneidad genómica en tumores sólidos, Evolución e heteroxeneidade xenómica en tumores sólidos

  • Tomás López, Laura
We know that each cancer is unique. Different tumors harbor different mutations, which determine the prognosis and the response to treatment. Therefore, in-depth genomic studies of individual tumors are key to understanding their particular history. However, the genome of a tumor is not stable: it changes both in space and in time. Tumor evolution results in ample genomic intratumor heterogeneity, and its study is essential to refine the treatment. Thus, we need to collect multiregional and longitudinal information to choose the optimal therapy and to keep track of the changes in the tumor. In our project, we will focus on colorectal cancer, one of the most prevalent cancer types. With genomic high-throughput sequencing and bioinformatic analysis, we aim to characterize the mutations in different tumor regions and the alterations potentially leading to resistance or relapse. We will use whole-genome and whole-exome data from multiregional biopsies to understand the evolutionary history of each patient's tumors., Sabemos que cada cáncer es único. Cada tumor tiene sus propias mutaciones que determinan el pronóstico y la respuesta al tratamiento. Por tanto, el estudio genómico detallado de tumores individuales es clave para entender su historia particular. Sin embargo, el genoma tumoral no es estable: cambia tanto en el espacio como en el tiempo. Esta evolución resulta en una gran heterogeneidad intratumoral, cuyo estudio es esencial para refinar el tratamiento. Por ello, necesitamos recopilar información multirregional y longitudinal que nos permita elegir la terapia óptima y monitorizar los cambios en el tumor. En nuestro proyecto nos centraremos en cáncer colorrectal, uno de los tipos de cáncer más comunes. Utilizando secuenciación genómica masiva y análisis bioinformático, buscamos caracterizar las mutaciones en diferentes regiones tumorales e identificar las posibles causas de la resistencia o la recaída. Utilizaremos datos de genoma y exoma completos de biopsias multirregionales para entender la historia evolutiva del tumor de cada paciente., Sabemos que cada cancro é único. Cada tumor ten as súas propias mutacións que determinan o prognóstico e a resposta ao tratamento. Polo tanto, o estudo xenómico pormenorizado de tumores individuais é clave para entender a súa historia particular. Sen embargo, o xenoma tumoral non é estable: cambia tanto no espazo como no tempo. Esta evolución resulta nunha gran heteroxeneidade intratumoral, cuxo estudo é esencial para refinar o tratamento. Por iso, necesitamos recadar información multirrexional e lonxitudinal que nos permita escoller a terapia óptima e vixiar os cambios no tumor. No noso proxecto centrarémonos en cancro colorrectal, un dos tipos de cancro máis comúns. Utilizando secuenciación xenómica masiva e análise bioinformático, buscamos caracterizar as mutacións en diferentes rexións tumorais e identificar as posibles causas da resistencia ou a recidiva. Utilizaremos datos de xenoma e exoma completos de biopsias multirrexionais para entender a historia evolutiva do tumor de cada paciente., Xunta de Galicia | Ref. ED481A2018/303, Agencia Estatal de Investigación | Ref. PID2019-106247GB-I00
Investigo. Repositorio Institucional de la Universidade de Vigo
Publicación Artículo científico (JournalArticle)

Single-cell phylogenies reveal changes in the evolutionary rate within cancer and healthy tissues

  • Borgsmüller, Nico
  • Valecha , Monica Vishnu
  • Kuipers, Jack
  • Beerenwinkel, Niko
  • Posada González, David
Cell lineages accumulate somatic mutations during organismal development, potentially leading to pathological states. The rate of somatic evolution within a cell population can vary due to multiple factors, including selection, a change in the mutation rate, or differences in the microenvironment. Here, we developed a statistical test called the Poisson Tree (PT) test to detect varying evolutionary rates among cell lineages, leveraging the phylogenetic signal of single-cell DNA sequencing (scDNA-seq) data. We applied the PT test to 24 healthy and cancer samples, rejecting a constant evolutionary rate in 11 out of 15 cancer and five out of nine healthy scDNA-seq datasets. In six cancer datasets, we identified subclonal mutations in known driver genes that could explain the rate accelerations of particular cancer lineages. Our findings demonstrate the efficacy of scDNA-seq for studying somatic evolution and suggest that cell lineages often evolve at different rates within cancer and healthy tissues., Agencia Estatal de Investigación | Ref. PID2019-106247GB-I00, Xunta de Galicia
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial genome sequencing of marine leukaemias reveals cancer contagion between clam species in the Seas of Southern Europe

  • Garcia-Souto, Daniel
  • Bruzos, Alicia L.
  • Diaz, Seila
  • Rocha, Sara
  • Pequeño-Valtierra, Ana
  • Roman-Lewis, Camila F
  • Alonso, Juana
  • Rodriguez, Rosana
  • Costas, Damian
  • Rodriguez-Castro, Jorge
  • Villanueva, Antonio
  • Valencia, José María
  • Annona, Giovanni
  • Tarallo, Andrea
  • Ricardo, Fernando
  • Bratoš Cetinić, Ana
  • Posada, David
  • Pasantes, Juan Jose
  • Tubio, Jose Mc
  • Silva, Luis
20 Pág., Clonally transmissible cancers are tumour lineages that are transmitted between individuals via the transfer of living cancer cells. In marine bivalves, leukaemia-like transmissible cancers, called hemic neoplasia (HN), have demonstrated the ability to infect individuals from different species. We performed whole-genome sequencing in eight warty venus clams that were diagnosed with HN, from two sampling points located more than 1000 nautical miles away in the Atlantic Ocean and the Mediterranean Sea Coasts of Spain. Mitochondrial genome sequencing analysis from neoplastic animals revealed the coexistence of haplotypes from two different clam species. Phylogenies estimated from mitochondrial and nuclear markers confirmed this leukaemia originated in striped venus clams and later transmitted to clams of the species warty venus, in which it survives as a contagious cancer. The analysis of mitochondrial and nuclear gene sequences supports all studied tumours belong to a single neoplastic lineage that spreads in the Seas of Southern Europe., We thank the Galicia Supercomputing Centre (CESGA) for the availability of informatic resources. JMCT, SR, SD, and JT are supported by European Research Council (ERC) Starting Grant 716,290 SCUBA CANCERS. ALB is supported by MINECO PhD fellowship BES-2016-078166. DG-S is supported by postdoctoral contract ED481B/2018/091 from Xunta de Galicia. DP is supported by ERC grant ERC-617457-PHYLOCANCER and by Spanish Ministry of Economy and Competitiveness (MINECO) grant PID2019-106247GB-I00. This research was partially funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement 730984, ASSEMBLE Plus project. CESAM got financial support from FCT/MEC (UIDP/50017/2020, UIDB/50017/2020)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intraline genomic heterogeneity of the triple-negative breast cancer MDA-MB-231-luc-GFP cell line

  • Varela-Rouco, Nair
  • Estévez-Gómez, Nuria
  • Fernández-Santiago, Cristóbal
  • Tomás, Laura
  • Pérez, Miriam
  • García-Souto, Daniel
  • Pasantes, Juan José
  • Piñeiro, Roberto
  • Alves, Joao M.
  • Posada, David
10 pages, 7 figures, 1 table, Cancer cell lines are valuable models for studying tumor biology, yet their genomic evolution during culture can compromise experimental reproducibility. We conducted a detailed genomic analysis of the triple-negative breast cancer cell line MDA-MB-231-luc-GFP, examining sublines obtained from different sources, at various time points, and across distinct passages. We introduce the concept of intraline heterogeneity (ILH) to highlight the genomic variability observed among these sublines. Our analyses revealed extensive genomic diversity, including differences in single-nucleotide variants (SNVs) and copy number alterations (CNAs). In particular, CNAs exhibited remarkable heterogeneity, with pronounced chromosomal gains and losses between sublines, underscoring the impact of genomic instability on ILH. These findings suggest that ILH may influence experimental outcomes, emphasizing the importance of considering passage-specific genomic characterization to ensure consistency and reliability in cancer research, This work has been funded by the Spanish MICINN grant PID2019–106247GB-100 and the EU through the 3DSecret project under the HORIZON-EIC-2022-PATHFINDEROPEN-01–01 programme (grant agreement 101099066), both awarded to D.P., and by the PhD fellowship PRE2020–092269, awarded to N.V.R, Peer reviewed